These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 24979671)
21. The number of FoxP3+ cells in transbronchial lung allograft biopsies does not predict bronchiolitis obliterans syndrome within the first five years after transplantation. Krustrup D; Iversen M; Martinussen T; Schultz HH; Andersen CB Clin Transplant; 2015 Mar; 29(3):179-84. PubMed ID: 25533723 [TBL] [Abstract][Full Text] [Related]
22. Local origin of mesenchymal cells in a murine orthotopic lung transplantation model of bronchiolitis obliterans. Mimura T; Walker N; Aoki Y; Manning CM; Murdock BJ; Myers JL; Lagstein A; Osterholzer JJ; Lama VN Am J Pathol; 2015 Jun; 185(6):1564-74. PubMed ID: 25848843 [TBL] [Abstract][Full Text] [Related]
23. The innate immune system in allograft rejection and tolerance. LaRosa DF; Rahman AH; Turka LA J Immunol; 2007 Jun; 178(12):7503-9. PubMed ID: 17548582 [TBL] [Abstract][Full Text] [Related]
24. CD28 superagonist antibody treatment attenuated obliterative bronchiolitis in rat allo-orthotopic tracheal transplantation by preferentially expanding Foxp3-expressing regulatory T cells. Shi Q; Niu Y; Cao H; Zhou X; Jiang S; Liu Z; Fan H Transplant Proc; 2012 May; 44(4):1060-6. PubMed ID: 22564625 [TBL] [Abstract][Full Text] [Related]
25. Adhesion molecules (E-selectin and ICAM-1) in pulmonary allograft rejection. Shreeniwas R; Schulman LL; Narasimhan M; McGregor CC; Marboe CC Chest; 1996 Nov; 110(5):1143-9. PubMed ID: 8915211 [TBL] [Abstract][Full Text] [Related]
26. Innate and adaptive immune responses in obliterative airway disease in rat tracheal allografts. Ropponen JO; Syrjälä SO; Krebs R; Nykänen A; Tikkanen JM; Lemström KB J Heart Lung Transplant; 2011 Jun; 30(6):707-16. PubMed ID: 21411341 [TBL] [Abstract][Full Text] [Related]
28. Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions. Chen G; Kheradmand T; Bryant J; Wang S; Tasch J; Wang JJ; Zhang Z; Luo X Am J Transplant; 2012 Nov; 12(11):2920-9. PubMed ID: 22883222 [TBL] [Abstract][Full Text] [Related]
29. A novel charcoal-induced model of obliterative bronchiolitis-like lesions: implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis. Lee AG; Wagner FM; Chen MF; Serrick C; Giaid A; Shennib H J Thorac Cardiovasc Surg; 1998 Apr; 115(4):822-7. PubMed ID: 9576217 [TBL] [Abstract][Full Text] [Related]
30. Chronic rejection in single-lung transplantation manifested by obliterative bronchiolitis. LoCicero J; Robinson PG; Fisher M J Thorac Cardiovasc Surg; 1990 Jun; 99(6):1059-62. PubMed ID: 2359323 [TBL] [Abstract][Full Text] [Related]
31. The role of miRNA-155 in the immunopathogenesis of obliterative airway disease in mice induced by circulating exosomes from human lung transplant recipients with chronic lung allograft dysfunction. Bansal S; Itabashi Y; Perincheri S; Poulson C; Bharat A; Smith MA; Bremner RM; Mohanakumar T Cell Immunol; 2020 Sep; 355():104172. PubMed ID: 32707293 [TBL] [Abstract][Full Text] [Related]
32. Patterns and significance of CD44 expression in lung allografts. Zander DS; Baz MA; Massey JK J Heart Lung Transplant; 1999 Jul; 18(7):646-53. PubMed ID: 10452340 [TBL] [Abstract][Full Text] [Related]
33. A novel mechanism for immune regulation after human lung transplantation. Mohanakumar T; Sharma M; Bansal S; Ravichandran R; Smith MA; Bremner RM J Thorac Cardiovasc Surg; 2019 May; 157(5):2096-2106. PubMed ID: 31288367 [TBL] [Abstract][Full Text] [Related]
34. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction. Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799 [TBL] [Abstract][Full Text] [Related]
35. Treatment with placenta-derived mesenchymal stem cells mitigates development of bronchiolitis obliterans in a murine model. Zhao Y; Gillen JR; Harris DA; Kron IL; Murphy MP; Lau CL J Thorac Cardiovasc Surg; 2014 May; 147(5):1668-1677.e5. PubMed ID: 24199758 [TBL] [Abstract][Full Text] [Related]
36. Prevention of cytomegalovirus infection-enhanced experimental obliterative bronchiolitis by antiviral prophylaxis or immunosuppression in rat tracheal allografts. Tikkanen JM; Kallio EA; Bruggeman CA; Koskinen PK; Lemström KB Am J Respir Crit Care Med; 2001 Aug; 164(4):672-9. PubMed ID: 11520736 [TBL] [Abstract][Full Text] [Related]
37. Development of obliterative bronchiolitis after allogeneic rat lung transplantation: implication of acute rejection and the time point of treatment. Hirt SW; You XM; Möller F; Boeke K; Starke M; Spranger U; Wottge HU J Heart Lung Transplant; 1999 Jun; 18(6):542-8. PubMed ID: 10395352 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of obliterative airway disease development following heterotopic murine tracheal transplantation by costimulatory molecule blockade using anti-CD40 ligand alone or in combination with donor bone marrow. Fernández FG; McKane B; Marshbank S; Patterson GA; Mohanakumar T J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S232-8. PubMed ID: 15993779 [TBL] [Abstract][Full Text] [Related]
39. Pluripotent allospecific CD8+ effector T cells traffic to lung in murine obliterative airway disease. West EE; Lavoie TL; Orens JB; Chen ES; Ye SQ; Finkelman FD; Garcia JG; McDyer JF Am J Respir Cell Mol Biol; 2006 Jan; 34(1):108-18. PubMed ID: 16195540 [TBL] [Abstract][Full Text] [Related]
40. Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future. Grossman EJ; Shilling RA Transl Res; 2009 Apr; 153(4):153-65. PubMed ID: 19304274 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]